Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Feb 1;132(2):e31-e33.
doi: 10.1213/ANE.0000000000005280.

In Response

Affiliations
Comment

In Response

Zhaosheng Jin et al. Anesth Analg. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The faculty received reimbursement for travel expenses attending the meeting. No honorarium was provided. T. J. Gan: Honoraria from Acacia, Edwards, Masimo, Medtronic, Merck and Mallinckrodt. S. Bergese: Acacia (Funding for Clinical Trial to Ohio State University). F. Chung has received research support from the Ontario Ministry of Health and Long-Term Care, University Health Network Foundation, Acacia Pharma, Medtronics grants to institution outside of the submitted work, Up-to-date royalties, STOP-Bang proprietary to University Health Network. Speaker honorarium from Baxter Pharma. P. Diemunsch: Ambu: Member of an advisors panel on airway management, Fisher & Paykel: Research Grants, paid conferences, French Government: Expert at the Court of Appeal, Acacia Pharma: Research Grants, MSD: Member of an advisory panel on ERAS. A. S. Habib: Funded Research: Pacira Biosciences, Avanos Medical Inc., Advisory Board: Takeda. A. L. Kovac: Merck (speaker’s bureau), Helsinn (speaker’s bureau), Mundipharma (speaker’s bureau), Acacia (speaker’s bureau). T. A. Meyer: Acacia, Neumentum. R. D. Urman: Merck (research funding); Medtronic (consulting fees and research funding); Takeda (consulting fees); Acacia (consulting fees and research funding); Posimir (consulting fees). S. Ayad: Pacira, Medtronic and Acacia. K. Candiotti: Research support-Acacia, Pfizer, Takeda; Consulting-Acacia, Pfizer, Takeda. T. L. Hedrick: MedEdicus. P. Kranke acted as investigator in phase III trials on amisulpride during the last 3 years. He gave invited lectures for FreseniusKabi (propofol), Grünenthal, CSL-Behring, TevaRatiopharm. H. S. Minkowitz: Acacia, AcelRX, Adynxx, Concentric, Durect, Heron, Merck, Mallinckrodt, Innocoll, Pacira, Neumentum, Westward, Trevena, Takeda. J. Morton: Medtronic, Olympus, Novo Nordisk.

Comment on

  • Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting.
    Gan TJ, Belani KG, Bergese S, Chung F, Diemunsch P, Habib AS, Jin Z, Kovac AL, Meyer TA, Urman RD, Apfel CC, Ayad S, Beagley L, Candiotti K, Englesakis M, Hedrick TL, Kranke P, Lee S, Lipman D, Minkowitz HS, Morton J, Philip BK. Gan TJ, et al. Anesth Analg. 2020 Aug;131(2):411-448. doi: 10.1213/ANE.0000000000004833. Anesth Analg. 2020. PMID: 32467512 Review.
  • Oral Perphenazine 8 mg: A Low-Cost, Efficacious Antiemetic Option.
    Williams BA, Holder-Murray JM, Esper SA, Subramaniam K, Skledar SJ, Kentor ML, Orebaugh SL, Mangione MP, Ibinson JW, Waters JH, Williams JP, Chelly JE. Williams BA, et al. Anesth Analg. 2021 Feb 1;132(2):e29-e31. doi: 10.1213/ANE.0000000000005279. Anesth Analg. 2021. PMID: 33449568 Free PMC article. No abstract available.

References

    1. Williams BA, Holder-Murray JM, Esper SA, et al. Oral perphenazine 8 mg: a low-cost, efficacious antiemetic option. Anesth Analg. 2021;132:e29–e31.
    1. Gan TJ, Belani KG, Bergese S, et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2020;131:411–448.
    1. Williams BA, Kentor ML, Skledar SJ, Orebaugh SL, Vallejo MC. Routine multimodal antiemesis including low-dose perphenazine in an ambulatory surgery unit of a university hospital: a 10-year history. Supplement to: Eliminating postoperative nausea and vomiting in outpatient surgery with multimodal strategies including low doses of nonsedating, off-patent antiemetics: Is “zero tolerance” achievable? ScientificWorldJournal. 2007;7:978–986.
    1. Holder-Murray J, Esper SA, Boisen ML, et al. Postoperative nausea and vomiting in patients undergoing colorectal surgery within an institutional enhanced recovery after surgery protocol: comparison of two prophylactic antiemetic regimens. Korean J Anesthesiol. 2019;72:344–350.
    1. Schnabel A, Eberhart LH, Muellenbach R, Morin AM, Roewer N, Kranke P. Efficacy of perphenazine to prevent postoperative nausea and vomiting: a quantitative systematic review. Eur J Anaesthesiol. 2010;27:1044–1051.

LinkOut - more resources